Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness - PubMed (original) (raw)
Review
Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness
James G Ryall et al. Biogerontology. 2008 Aug.
Abstract
Some of the most serious consequences of ageing are its effects on skeletal muscle. The term 'sarcopenia' describes the slow but progressive loss of muscle mass with advancing age and is characterised by a deterioration of muscle quantity and quality leading to a gradual slowing of movement and a decline in strength. The loss of muscle mass and strength is thought to be attributed to the progressive atrophy and loss of individual muscle fibres associated with the loss of motor units, and a concomitant reduction in muscle 'quality' due to the infiltration of fat and other non-contractile material. These age-related changes in skeletal muscle can be largely attributed to the complex interaction of factors affecting neuromuscular transmission, muscle architecture, fibre composition, excitation-contraction coupling, and metabolism. Given the magnitude of the growing public health problems associated with sarcopenia, there is considerable interest in the development and evaluation of therapeutic strategies to attenuate, prevent, or ultimately reverse age-related muscle wasting and weakness. The aim is to review our current understanding of some of the cellular and molecular mechanisms responsible for age-related changes in skeletal muscle.
Similar articles
- Tackling Australia's future health problems: developing strategies to combat sarcopenia--age-related muscle wasting and weakness.
Lynch GS. Lynch GS. Intern Med J. 2004 May;34(5):294-6. doi: 10.1111/j.1444-0903.2004.00568.x. Intern Med J. 2004. PMID: 15151679 Review. - [Age-related muscle mass loss].
Czarkowska-Paczek B, Milczarczyk S. Czarkowska-Paczek B, et al. Przegl Lek. 2006;63(8):658-61. Przegl Lek. 2006. PMID: 17441378 Review. Polish. - Age-related changes in the structure and function of skeletal muscles.
Faulkner JA, Larkin LM, Claflin DR, Brooks SV. Faulkner JA, et al. Clin Exp Pharmacol Physiol. 2007 Nov;34(11):1091-6. doi: 10.1111/j.1440-1681.2007.04752.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17880359 Review. - Myotendinous plasticity to ageing and resistance exercise in humans.
Reeves ND, Narici MV, Maganaris CN. Reeves ND, et al. Exp Physiol. 2006 May;91(3):483-98. doi: 10.1113/expphysiol.2005.032896. Epub 2006 Feb 9. Exp Physiol. 2006. PMID: 16469817 Review. - Update on emerging drugs for sarcopenia - age-related muscle wasting.
Lynch GS. Lynch GS. Expert Opin Emerg Drugs. 2008 Dec;13(4):655-73. doi: 10.1517/14728210802544476. Expert Opin Emerg Drugs. 2008. PMID: 19046133 Review.
Cited by
- Broadening the selection criteria for Astronauts undertaking long-term space travel.
Yasuda H, Sihver L. Yasuda H, et al. Front Nucl Med. 2022 Nov 4;2:997718. doi: 10.3389/fnume.2022.997718. eCollection 2022. Front Nucl Med. 2022. PMID: 39354986 Free PMC article. No abstract available. - Association of phase angle with sarcopenia in patients undergoing maintenance hemodialysis: A case-control study.
Alirezaei A, Miladipour A, Asgari N, Latifi M, Fazeli SA. Alirezaei A, et al. J Res Med Sci. 2024 Jul 12;29:40. doi: 10.4103/jrms.jrms_38_24. eCollection 2024. J Res Med Sci. 2024. PMID: 39239086 Free PMC article. - Effects of Paraspinal Intramuscular Injection of Atelocollagen in Patients with Chronic Low Back Pain: A Retrospective Observational Study.
Kim TK, Gil HY. Kim TK, et al. J Clin Med. 2024 Apr 29;13(9):2607. doi: 10.3390/jcm13092607. J Clin Med. 2024. PMID: 38731135 Free PMC article. - Small extracellular vesicles from young plasma reverse age-related functional declines by improving mitochondrial energy metabolism.
Chen X, Luo Y, Zhu Q, Zhang J, Huang H, Kan Y, Li D, Xu M, Liu S, Li J, Pan J, Zhang L, Guo Y, Wang B, Qi G, Zhou Z, Zhang CY, Fang L, Wang Y, Chen X. Chen X, et al. Nat Aging. 2024 Jun;4(6):814-838. doi: 10.1038/s43587-024-00612-4. Epub 2024 Apr 16. Nat Aging. 2024. PMID: 38627524 Free PMC article. - The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway.
Huang Q, Chen J, Liao S, Long J, Fang R, He Y, Chen P, Liu D. Huang Q, et al. Biogerontology. 2024 Jun;25(3):567-581. doi: 10.1007/s10522-024-10093-y. Epub 2024 Feb 26. Biogerontology. 2024. PMID: 38403802
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical